OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
May 25, 2024
In an ASGCT Panel on nucleic acid- and cell-based vaccines in oncology, work on a personalized mRNA vaccine was highlighted.
The partnership aims to provide end-to-end development and manufacturing for biopharmaceutical drug substance and drug product.
May 24, 2024
With this acquisition, Merck KGaA will have the capability to offer integrated services for viral vector manufacturing.
May 21, 2024
Webinar Date/Time: Mon, Jun 24, 2024 11:00 AM EDT
May 20, 2024
The new facility will be the company’s first to offer full manufacturing processing for antibody drug conjugates.
May 18, 2024
Bari Kowal, senior vice-president, head Development Operations & Portfolio Management, Regeneron, discussed the utility of AI and how it can benefit R&D work.
A combination of rapid sterility methods with the industry standard compendial method should ensure maximum safety.
May 17, 2024
The new 80,000-square-foot facility will increase production of the company’s freeze-drying equipment.
May 16, 2024
Determining E&L risk from single-use components can be used to build the level of extractable profiling and PERLs.
May 14, 2024
The drug discovery company intends for this new site to increase its reach in the region, supporting growing demands from its Asia-Pacific consumers.